Allogeneic Stem Cell Transplantation for Chronic Myeloproliferative Disorders and Myelodysplastic Syndromes: The Question Is “When?”
- 1 August 2003
- journal article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 78 (8) , 941-943
- https://doi.org/10.1016/s0025-6196(11)63139-x
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Hematopoietic Cell Transplantation for Adult Patients With Myelodysplastic Syndromes and Myeloproliferative DisordersMayo Clinic Proceedings, 2003
- Polycythemia Vera: A Comprehensive Review and Clinical RecommendationsMayo Clinic Proceedings, 2003
- 72 Allogeneic bone marrow transplantation for myelofibrosis due to agnogenic myeloid metaplasia (AMM) and essential thrombocytosis (ET): Experience of two bone marrow transplant centersTransplantation and Cellular Therapy, 2003
- Allogeneic Hematopoietic Stem Cell TransplantationArchives of internal medicine (1960), 2002
- Current opinion in essential thrombocythemia: pathogenesis, diagnosis, and managementBlood Reviews, 2001
- Unexplained Pulmonary Hypertension in Chronic Myeloproliferative DisordersChest, 2001
- Myelofibrosis with Myeloid MetaplasiaNew England Journal of Medicine, 2000
- Myelofibrosis with Myeloid MetaplasiaNew England Journal of Medicine, 2000
- Myelofibrosis with myeloid metaplasia in young indidviduals: disease characteristics, prognostic factors and identification of risk groupsBritish Journal of Haematology, 1998
- Hydroxyurea for Patients with Essential Thrombocythemia and a High Risk of ThrombosisNew England Journal of Medicine, 1995